Drug-induced gingival enlargement. 2014

Michal Straka, and Ivan Varga, and Ivan Erdelský, and Michaela Straka-Trapezanlidis, and Jana Krňoulová
Department of Dentistry, Slovak Medical University, Bratislava, Slovakia.

OBJECTIVE Side effect of medicamentous treatment in hypertension therapy and angina pectoris with calcium channel blockers related to fibrotic gingival enlargement were examined. METHODS In our study we deal with clinico-histopathological and microbiological knowledge from this field underpinned by two case reports treated with antihypertensive therapy using calcium channel blockers. In the first case report we were largely concerned with microbiological findings from the area of periodontal pseudopockets diagnosed through a DNA analysis and appropriate antibiotic therapy. In a patient treated with a preparation from amlodipine group we proceeded to a complex treatment involving the change of hypertension therapy, introduction of professional and home oral hygiene and also following surgical and prosthetico-aesthetic rehabilitation. RESULTS Case Report 1 who was for a long term medicated with a preparation from the nifedipine group of antihypertensives we detected the presence of periodontal pseudopockets with probing depth of 4 to 7 mm with positive BOP and with marked rigid fibrotic gingival enlargement accompanied with considerable foetor ex ore. In a patient from the Case Report 2 who was for a long term medicated with a preparation from the amlodipine group of antihypertensives with large gingival overgrowth angiogenesis was characterized by cuboidal endothelial cell lining. In the samples under a layer of stratified epithelium there was present dense fibrous connective tissue comprising largely of collagen fiber bundles. CONCLUSIONS Bacterial composition in the patient with a high degree of gingival enlargement and periodontal pseudopockets 4 to 7 mm deep represented a typical spectrum of bacteria occuring in chronic forms of periodontitis. However, we cannot determine, if such distribution of bacteria was primary before the application of nifedipine antihypertensives, or it originated later after the formation of typical anaerobic setting of false periodontal pockets.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002121 Calcium Channel Blockers A class of drugs that act by selective inhibition of calcium influx through cellular membranes. Calcium Antagonists, Exogenous,Calcium Blockaders, Exogenous,Calcium Channel Antagonist,Calcium Channel Blocker,Calcium Channel Blocking Drug,Calcium Inhibitors, Exogenous,Channel Blockers, Calcium,Exogenous Calcium Blockader,Exogenous Calcium Inhibitor,Calcium Channel Antagonists,Calcium Channel Blocking Drugs,Exogenous Calcium Antagonists,Exogenous Calcium Blockaders,Exogenous Calcium Inhibitors,Antagonist, Calcium Channel,Antagonists, Calcium Channel,Antagonists, Exogenous Calcium,Blockader, Exogenous Calcium,Blocker, Calcium Channel,Blockers, Calcium Channel,Calcium Blockader, Exogenous,Calcium Inhibitor, Exogenous,Channel Antagonist, Calcium,Channel Blocker, Calcium,Inhibitor, Exogenous Calcium
D005260 Female Females
D005881 Gingiva Oral tissue surrounding and attached to TEETH. Gums,Interdental Papilla,Papilla, Interdental,Gum
D005882 Gingival Diseases Diseases involving the GINGIVA. Epulis,Gingivosis,Epulides,Disease, Gingival,Diseases, Gingival,Gingival Disease,Gingivoses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000959 Antihypertensive Agents Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. Anti-Hypertensive,Anti-Hypertensive Agent,Anti-Hypertensive Drug,Antihypertensive,Antihypertensive Agent,Antihypertensive Drug,Anti-Hypertensive Agents,Anti-Hypertensive Drugs,Anti-Hypertensives,Antihypertensive Drugs,Antihypertensives,Agent, Anti-Hypertensive,Agent, Antihypertensive,Agents, Anti-Hypertensive,Agents, Antihypertensive,Anti Hypertensive,Anti Hypertensive Agent,Anti Hypertensive Agents,Anti Hypertensive Drug,Anti Hypertensive Drugs,Anti Hypertensives,Drug, Anti-Hypertensive,Drug, Antihypertensive,Drugs, Anti-Hypertensive,Drugs, Antihypertensive

Related Publications

Michal Straka, and Ivan Varga, and Ivan Erdelský, and Michaela Straka-Trapezanlidis, and Jana Krňoulová
August 2013, General dentistry,
Michal Straka, and Ivan Varga, and Ivan Erdelský, and Michaela Straka-Trapezanlidis, and Jana Krňoulová
May 2013, Compendium of continuing education in dentistry (Jamesburg, N.J. : 1995),
Michal Straka, and Ivan Varga, and Ivan Erdelský, and Michaela Straka-Trapezanlidis, and Jana Krňoulová
January 2012, Journal of dental hygiene : JDH,
Michal Straka, and Ivan Varga, and Ivan Erdelský, and Michaela Straka-Trapezanlidis, and Jana Krňoulová
June 2021, BMJ (Clinical research ed.),
Michal Straka, and Ivan Varga, and Ivan Erdelský, and Michaela Straka-Trapezanlidis, and Jana Krňoulová
October 2004, Journal of periodontology,
Michal Straka, and Ivan Varga, and Ivan Erdelský, and Michaela Straka-Trapezanlidis, and Jana Krňoulová
October 2000, Annals of the Royal Australasian College of Dental Surgeons,
Michal Straka, and Ivan Varga, and Ivan Erdelský, and Michaela Straka-Trapezanlidis, and Jana Krňoulová
January 2006, Journal of periodontology,
Michal Straka, and Ivan Varga, and Ivan Erdelský, and Michaela Straka-Trapezanlidis, and Jana Krňoulová
August 2021, BMJ case reports,
Michal Straka, and Ivan Varga, and Ivan Erdelský, and Michaela Straka-Trapezanlidis, and Jana Krňoulová
October 2017, Clinical case reports,
Michal Straka, and Ivan Varga, and Ivan Erdelský, and Michaela Straka-Trapezanlidis, and Jana Krňoulová
May 2014, BMJ case reports,
Copied contents to your clipboard!